3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Leukemia
4
Recurrence
3
Multiple Myeloma
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large-Cell, Anaplastic
3
Burkitt Lymphoma
3
Neoplasms, Plasma Cell
2
Myelodysplastic Syndromes
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphohistiocytosis, Hemophagocytic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Epstein-Barr Virus Infections
2
Dendritic Cell Sarcoma, Interdigitating
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Sezary Syndrome
1
Sarcoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Pneumonia, Pneumocystis
1
Pneumonia
1
Neuroma
1
Interventions
Vincristine
2
Doxorubicin
2
Cyclophosphamide
2
prednylidene
1
pirarubicin
1
etoposide phosphate
1
Sensitivity and Specificity
1
Prednisone
1
Prednisolone
1
Methylprednisolone
1
Methotrexate
1
Ifosfamide
1
Gemcitabine
1
Etoposide
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Enteropathy-Associated T-Cell Lymphoma
×
Methylprednisolone
×
Clear all
NCT01719835
2018-03-15
CHEMO-T
Royal Marsden NHS Foundation Trust
Phase 2
Unknown
87 enrolled